
Management status of suspected unexpected serious adverse reaction reports in clinical trial sites
Liao Juan, Ma Yuanji, Tang Hong
Management status of suspected unexpected serious adverse reaction reports in clinical trial sites
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |